[The value of alpha-methylacyl-CoA racemase expression in the progression of colonic carcinoma]

Rev Esp Patol. 2017 Jan-Mar;50(1):15-21. doi: 10.1016/j.patol.2016.04.003. Epub 2016 May 20.
[Article in Spanish]

Abstract

Alpha-methylacyl-CoA racemase (AMACR) expression has been demonstrated in several normal tissues and in diverse types of carcinoma. Our aim was to analyze the immunohistochemical expression of AMACR in the sequence-progression of colonic cancer. We studied 237 cases, including samples of normal mucosa of the colon, adenomas with different degrees of dysplasia, colonic carcinomas, lymph nodes and liver metastases of colonic carcinomas. A scale of intensity and percentage of expression was used to analyze the AMACR immunohistochemical profile. The expression was nearly absent in samples of normal mucosa, increased in both adenomas and carcinomas, decreased in lymph node metastases but was significantly increased in liver metastases.

Keywords: AMACR; Carcinoma de colon; Colonic carcinoma; Immunohistochemistry; Inmunohistoquímica; P504S; Racemasa; Racemase.

MeSH terms

  • Adenocarcinoma / enzymology*
  • Adenoma / enzymology
  • Aged
  • Aged, 80 and over
  • Colon / enzymology
  • Colonic Polyps / enzymology
  • Disease Progression
  • Female
  • Humans
  • Intestinal Mucosa / enzymology
  • Liver Neoplasms / enzymology
  • Liver Neoplasms / secondary
  • Male
  • Middle Aged
  • Neoplasm Proteins / analysis*
  • Racemases and Epimerases / analysis*
  • Sampling Studies

Substances

  • Neoplasm Proteins
  • Racemases and Epimerases
  • alpha-methylacyl-CoA racemase